At last there is light at the end of the tunnel,But what will happen to all the infected people before 2015 which is still under probability. Clinical
trials of a preventative vaccine for the Ebola virus made by British
pharma company GlaxoSmithKline may begin next month and made available
by 2015, the World Health Organization said on Saturday.
"We
are targeting September for the start of clinical trials, first in the
United States and certainly in African countries, since that's where we
have the cases," Jean-Marie Okwo Bele, the WHO's head of vaccines and
immunisation, told French radio.
He
said he was optimistic about making the vaccine commercially available.
"We think that if we start in September, we could already have results
by the end of the year.
"And since this is an emergency, we can put emergency procedures in place ... so that we can have a vaccine available by 2015."
There
is currently no available cure or vaccine for Ebola, a virus that
causes severe fever and, in the worst cases, unstoppable bleeding.
It
has claimed close to 1,000 lives in the latest epidemic to spread
across West Africa this year. Fatality rates can approach 90 percent,
although the latest outbreak has killed around 55 to 60 percent of those
infected.
Several
vaccines are being tested, and a treatment made by San Diego-based Mapp
Biopharmaceutical, ZMapp, has shown promising results on monkeys and
may have been effective in treating two Americans recently infected in
Africa.
Source: Agenda
No comments:
Post a Comment